Quarterly report · Q1
4583.TEDINET S100TEU8
Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥130m | 2024-01-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥682m | 2023-01-01 → 2023-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥169m | 2023-01-01 → 2023-03-31 | Standalone | Net sales |
| Operating income | −¥322m | 2024-01-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥226m | 2023-01-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥303m | 2024-01-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.2bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥227m | 2023-01-01 → 2023-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥303m | 2024-01-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥226m | 2023-01-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥304m | 2024-01-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥1.2bn | 2023-01-01 → 2023-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥228m | 2023-01-01 → 2023-03-31 | Standalone | Profit loss |
| Total assets | ¥1.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥1.8bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥2.1bn | at 2023-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥506m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥594m | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2023-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-5.6 | 2024-01-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-24.62 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.7 | 2023-01-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.4% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.1% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 55,720,600 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 52,640,200 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,423,500 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥133m |
| jpcrp040300-q1r_E26096-000Drug Discovery And Developmentreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥246m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥130m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥130m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥57m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-03-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-03-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-03-31 | −¥189m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥128m |
| jpcrp040300-q1r_E26096-000Drug Discovery And Developmentreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥194m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥169m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥169m |
| jpcrp040300-q1r_E26096-000Drug Discovery Supportreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥96m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-03-31 | ¥169m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-03-31 | ¥169m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | −¥98m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 321
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有 限 責 任 監 査 法 人 ト ー マ ツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)鈴 木 基 之 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)三 浦 靖 晃 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 169404000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 129644000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 682464000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -227433000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -303019000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1217240000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -227683000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -304024000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1220018000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 2097017000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 2587752000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2388422000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 48423500 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 55720600 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 52640200 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 1562132000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 1247567000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1157723000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 2085676000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 1753934000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1751454000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -4.70 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -5.60 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -24.62 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.743 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.704 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.651 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 55720600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 56198700 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 55720600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 56198700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 6100 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |